SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001385508-19-000086
Filing Date
2019-08-13
Accepted
2019-08-13 16:02:46
Documents
1
Period of Report
2019-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156572654992515.html 4  
1 FORM 4 wf-form4_156572654992515.xml 4 3550
  Complete submission text file 0001385508-19-000086.txt   5126
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Issuer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 1000 Metal Mining
Assistant Director 9

Mailing Address 1640 MARENGO STREET LOS ANGELES CA 90033
Business Address
O'Toole David D (Reporting) CIK: 0001491140 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38193 | Film No.: 191020596